3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
7
Thoracic
2
Head & Neck
2
Sarcoma
1
Other solid neoplasm
1
Lymphoid
1
Gynecologic
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Advanced Solid Tumors
42
Advanced Solid Tumor
27
Solid Tumor
19
Solid Tumors
17
Mesothelioma, Malignant
8
Mesothelioma
6
Advanced Malignant Solid Tumor
6
Solid Tumor Cancer
5
Solid Tumor Malignancies
4
Metastatic Solid Tumors
4
Solid Tumor, Adult
3
Malignant Solid Tumors
3
Hematopoietic and Lymphatic System Neoplasm
3
Advanced Malignant Solid Tumors
3
Pancreas Adenocarcinoma (MSI-H)
2
Ovarian Neoplasms
2
Malignant Solid Neoplasm
2
Locally Advanced or Metastatic Solid Tumors
2
Head and Neck Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Advanced/Metastatic Solid Tumors
2
Advanced Solid Tumors Cancer
2
mCRPC or Advanced/Metastatic Solid Tumors
1
Unresectable Solid Tumors
1
Unresectable Locally Advanced or Metastatic Solid Tumors
1
Triple Negative Breast Neoplasms
1
Treatment-Refractory Solid Tumors
1
Solid Tumors, Adult
1
Solid Tumors with FGFR2 Alterations, Adult
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Clear-cell metastatic renal cell carcinoma
×
Other solid neoplasm
×
Clear all
NCT05698238
2023-03-15
CAMP1
Mabpro, a.s.
Phase 1
Not yet recruiting
50 enrolled